{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:07:48Z","timestamp":1769062068035,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,2,9]],"date-time":"2009-02-09T00:00:00Z","timestamp":1234137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,2,9]],"date-time":"2009-02-09T00:00:00Z","timestamp":1234137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2009,3,26]]},"DOI":"10.1038\/onc.2008.502","type":"journal-article","created":{"date-parts":[[2009,2,9]],"date-time":"2009-02-09T11:11:00Z","timestamp":1234177860000},"page":"1518-1528","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells"],"prefix":"10.1038","volume":"28","author":[{"given":"A","family":"Prasad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-W","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M V R","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Boominathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E P","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J E","family":"Groopman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,9]]},"reference":[{"key":"BFonc2008502_CR1","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.coi.2007.05.004","volume":"19","author":"JM Adams","year":"2007","unstructured":"Adams JM, Cory S . (2007). Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol 19: 488\u2013496.","journal-title":"Curr Opin Immunol"},{"key":"BFonc2008502_CR2","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1084\/jem.190.12.1879","volume":"190","author":"A Alam","year":"1999","unstructured":"Alam A, Cohen LY, Aouad S, Sekaly RP . (1999). Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J Exp Med 190: 1879\u20131890.","journal-title":"J Exp Med"},{"key":"BFonc2008502_CR3","doi-asserted-by":"publisher","first-page":"13613","DOI":"10.1073\/pnas.0405454101","volume":"101","author":"M Aoki","year":"2004","unstructured":"Aoki M, Jiang H, Vogt PK . (2004). Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc Natl Acad Sci USA 101: 13613\u201313617.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2008502_CR4","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.1158\/0008-5472.CAN-07-0881","volume":"67","author":"G Armengol","year":"2007","unstructured":"Armengol G, Rojo F, Castellvi J, Iglesias C, Cuatrecasas M, Pons B et al. (2007). 4E-binding protein 1: a key molecular \u2018funnel factor\u2019 in human cancer with clinical implications. Cancer Res 67: 7551\u20137555.","journal-title":"Cancer Res"},{"key":"BFonc2008502_CR5","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.biocel.2007.04.026","volume":"39","author":"F Bertoni","year":"2007","unstructured":"Bertoni F, Ponzoni M . (2007). The cellular origin of mantle cell lymphoma. Int J Biochem Cell Biol 39: 1747\u20131753.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFonc2008502_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/hon.767","volume":"24","author":"F Bertoni","year":"2006","unstructured":"Bertoni F, Rinaldi A, Zucca E, Cavalli F . (2006). Update on the molecular biology of mantle cell lymphoma. Hematol Oncol 24: 22\u201327.","journal-title":"Hematol Oncol"},{"key":"BFonc2008502_CR7","doi-asserted-by":"publisher","first-page":"10543","DOI":"10.1128\/MCB.25.23.10543-10555.2005","volume":"25","author":"SC Brady","year":"2005","unstructured":"Brady SC, Allan LA, Clarke PR . (2005). Regulation of caspase 9 through phosphorylation by protein kinase C zeta in response to hyperosmotic stress. Mol Cell Biol 25: 10543\u201310555.","journal-title":"Mol Cell Biol"},{"key":"BFonc2008502_CR8","first-page":"4197","volume":"25","author":"SC Brauns","year":"2005","unstructured":"Brauns SC, Dealtry G, Milne P, Naude R, Van de Venter M . (2005). Caspase-3 activation and induction of PARP cleavage by cyclic dipeptide cyclo(Phe-Pro) in HT-29 cells. Anticancer Res 25: 4197\u20134202.","journal-title":"Anticancer Res"},{"key":"BFonc2008502_CR9","first-page":"115","volume":"36","author":"E Campo","year":"1999","unstructured":"Campo E, Raffeld M, Jaffe ES . (1999). Mantle-cell lymphoma. Semin Hematol 36: 115\u2013127.","journal-title":"Semin Hematol"},{"key":"BFonc2008502_CR10","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1093\/hmg\/ddh195","volume":"13","author":"RJ de Leeuw","year":"2004","unstructured":"de Leeuw RJ, Davies JJ, Rosenwald A, Bebb G, Gascoyne RD, Dyer MJ et al. (2004). Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. Hum Mol Genet 13: 1827\u20131837.","journal-title":"Hum Mol Genet"},{"key":"BFonc2008502_CR11","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1038\/onc.2008.301","volume":"27","author":"DN Dhanasekaran","year":"2008","unstructured":"Dhanasekaran DN, Reddy EP . (2008). JNK signaling in apoptosis. Oncogene 27: 6245\u20136251.","journal-title":"Oncogene"},{"key":"BFonc2008502_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S . (2007). Apotosis: a review of programmed cell death. Toxicol pathol 35: 495\u2013516.","journal-title":"Toxicol pathol"},{"key":"BFonc2008502_CR13","doi-asserted-by":"publisher","first-page":"11345","DOI":"10.1158\/0008-5472.CAN-05-2159","volume":"65","author":"S Ely","year":"2005","unstructured":"Ely S, Di Liberto M, Niesvizky R, Baughn LB, Cho HJ, Hatada EN et al. (2005). Mutually exclusive cyclin-dependent kinase 4\/cyclin D1 and cyclin-dependent kinase 6\/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma. Cancer Res 65: 11345\u201311353.","journal-title":"Cancer Res"},{"key":"BFonc2008502_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","volume":"30","author":"JA Fresno Vara","year":"2004","unstructured":"Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M . (2004). PI3K\/Akt signalling pathway and cancer. Cancer Treat Rev 30: 193\u2013204.","journal-title":"Cancer Treat Rev"},{"key":"BFonc2008502_CR15","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1101\/gad.887201","volume":"15","author":"AC Gingras","year":"2001","unstructured":"Gingras AC, Raught B, Sonenberg N . (2001). Regulation of translation initiation by FRAP\/mTOR. Genes Dev 15: 807\u2013826.","journal-title":"Genes Dev"},{"key":"BFonc2008502_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ccr.2005.02.009","volume":"7","author":"K Gumireddy","year":"2005","unstructured":"Gumireddy K, Reddy MV, Cosenza SC, Boominathan R, Baker SJ, Papathi N et al. (2005). ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent. Cancer Cell 7: 275\u2013286.","journal-title":"Cancer Cell"},{"key":"BFonc2008502_CR17","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1182\/blood-2005-11-026344","volume":"110","author":"N Kawamata","year":"2007","unstructured":"Kawamata N, Chen J, Koeffler HP . (2007). Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells. Blood 110: 2667\u20132673.","journal-title":"Blood"},{"key":"BFonc2008502_CR18","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/cncr.20947","volume":"103","author":"R Kim","year":"2005","unstructured":"Kim R . (2005). Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 103: 1551\u20131560.","journal-title":"Cancer"},{"key":"BFonc2008502_CR19","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1073\/pnas.90.8.3516","volume":"90","author":"KM Kozopas","year":"1993","unstructured":"Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW . (1993). MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 90: 3516\u20133520.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2008502_CR20","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1365-2141.1991.tb08582.x","volume":"77","author":"D Leroux","year":"1991","unstructured":"Leroux D, Le Marc\u2019Hadour F, Gressin R, Jacob MC, Keddari E, Monteil M et al. (1991). Non-Hodgkin's lymphomas with t(11;14)(q13;q32): a subset of mantle zone\/intermediate lymphocytic lymphoma? Br J Haematol 77: 346\u2013353.","journal-title":"Br J Haematol"},{"key":"BFonc2008502_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1615\/CritRevOncog.v13.i2.10","volume":"13","author":"DJ Liao","year":"2007","unstructured":"Liao DJ, Thakur A, Wu J, Biliran H, Sarkar FH . (2007). Perspectives on c-Myc, cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy. Crit Rev Oncog 13: 93\u2013158.","journal-title":"Crit Rev Oncog"},{"key":"BFonc2008502_CR22","doi-asserted-by":"publisher","first-page":"7903","DOI":"10.1128\/MCB.20.21.7903-7913.2000","volume":"20","author":"S Lin","year":"2000","unstructured":"Lin S, Wang W, Wilson GM, Yang X, Brewer G, Holbrook NJ et al. (2000). Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover. Mol Cell Biol 20: 7903\u20137913.","journal-title":"Mol Cell Biol"},{"key":"BFonc2008502_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0092-8674(00)81589-5","volume":"94","author":"X Luo","year":"1998","unstructured":"Luo X, Budihardjo I, Zou H, Slaughter C, Wang X . (1998). Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481\u2013490.","journal-title":"Cell"},{"key":"BFonc2008502_CR24","doi-asserted-by":"publisher","first-page":"10657","DOI":"10.1158\/0008-5472.CAN-05-2087","volume":"65","author":"SA Martin","year":"2005","unstructured":"Martin SA, Ouchi T . (2005). BRCA1 phosphorylation regulates caspase-3 activation in UV-induced apoptosis. Cancer Res 65: 10657\u201310662.","journal-title":"Cancer Res"},{"key":"BFonc2008502_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1741-7007-2-24","volume":"2","author":"DR Mattoon","year":"2004","unstructured":"Mattoon DR, Lamothe B, Lax I, Schlessinger J . (2004). The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K\/Akt cell survival pathway. BMC Biol 2: 24.","journal-title":"BMC Biol"},{"key":"BFonc2008502_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1023\/B:APPT.0000045801.15585.dd","volume":"9","author":"M Osaki","year":"2004","unstructured":"Osaki M, Oshimura M, Ito H . (2004). PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9: 667\u2013676.","journal-title":"Apoptosis"},{"key":"BFonc2008502_CR27","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1038\/sj.onc.1210350","volume":"26","author":"IW Park","year":"2007","unstructured":"Park IW, Reddy MV, Reddy EP, Groopman JE . (2007). Evaluation of novel cell cycle inhibitors in mantle cell lymphoma. Oncogene 26: 5635\u20135642.","journal-title":"Oncogene"},{"key":"BFonc2008502_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1189\/jlb.1106678","volume":"82","author":"A Prasad","year":"2007","unstructured":"Prasad A, Qamri Z, Wu J, Ganju RK . (2007). Slit-2\/Robo-1 modulates the CXCL12\/CXCR4-induced chemotaxis of T cells. J Leukoc Biol 82: 465\u2013476.","journal-title":"J Leukoc Biol"},{"key":"BFonc2008502_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1357-2725(98)00131-9","volume":"31","author":"B Raught","year":"1999","unstructured":"Raught B, Gingras AC . (1999). eIF4E activity is regulated at multiple levels. Int J Biochem Cell Biol 31: 43\u201357.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFonc2008502_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1021\/jm701077b","volume":"51","author":"MV Reddy","year":"2008","unstructured":"Reddy MV, Mallireddigari MR, Cosenza SC, Pallela VR, Iqbal NM, Robell KA et al. (2008). Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents. J Med Chem 51: 86\u2013100.","journal-title":"J Med Chem"},{"key":"BFonc2008502_CR31","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","volume":"130","author":"EG Rizzatti","year":"2005","unstructured":"Rizzatti EG, Falcao RP, Panepucci RA, Proto-Siqueira R, Anselmo-Lima WT, Okamoto OK et al. (2005). Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. Br J Haematol 130: 516\u2013526.","journal-title":"Br J Haematol"},{"key":"BFonc2008502_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","volume":"3","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E et al. (2003). The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3: 185\u2013197.","journal-title":"Cancer Cell"},{"key":"BFonc2008502_CR33","doi-asserted-by":"publisher","first-page":"21176","DOI":"10.1074\/jbc.270.36.21176","volume":"270","author":"IB Rosenwald","year":"1995","unstructured":"Rosenwald IB, Kaspar R, Rousseau D, Gehrke L, Leboulch P, Chen JJ et al. (1995). Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels. J Biol Chem 270: 21176\u201321180.","journal-title":"J Biol Chem"},{"key":"BFonc2008502_CR34","doi-asserted-by":"publisher","first-page":"7358","DOI":"10.1128\/MCB.13.12.7358","volume":"13","author":"IB Rosenwald","year":"1993","unstructured":"Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV . (1993). Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 13: 7358\u20137363.","journal-title":"Mol Cell Biol"},{"key":"BFonc2008502_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nm1042","volume":"10","author":"D Ruggero","year":"2004","unstructured":"Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C et al. (2004). The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med 10: 484\u2013486.","journal-title":"Nat Med"},{"key":"BFonc2008502_CR36","doi-asserted-by":"publisher","first-page":"10964","DOI":"10.1074\/jbc.M407874200","volume":"280","author":"Y Shi","year":"2005","unstructured":"Shi Y, Sharma A, Wu H, Lichtenstein A, Gera J . (2005). Cyclin D1 and c-myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK- and ERK-dependent pathway. J Biol Chem 280: 10964\u201310973.","journal-title":"J Biol Chem"},{"key":"BFonc2008502_CR37","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00277-005-1065-x","volume":"84","author":"K Vermeulen","year":"2005","unstructured":"Vermeulen K, Van Bockstaele DR, Berneman ZN . (2005). Apoptosis: mechanisms and relevance in cancer. Ann Hematol 84: 627\u2013639.","journal-title":"Ann Hematol"},{"key":"BFonc2008502_CR38","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature02369","volume":"428","author":"HG Wendel","year":"2004","unstructured":"Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S et al. (2004). Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428: 332\u2013337.","journal-title":"Nature"},{"key":"BFonc2008502_CR39","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1200\/JCO.2005.55.017","volume":"23","author":"TE Witzig","year":"2005","unstructured":"Witzig TE . (2005). Current treatment approaches for mantle-cell lymphoma. J Clin Oncol 23: 6409\u20136414.","journal-title":"J Clin Oncol"},{"key":"BFonc2008502_CR40","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1016\/S0021-9258(18)53358-5","volume":"268","author":"J Yoder-Hill","year":"1993","unstructured":"Yoder-Hill J, Pause A, Sonenberg N, Merrick WC . (1993). The p46 subunit of eukaryotic initiation factor (eIF)-4F exchanges with eIF-4A. J Biol Chem 268: 5566\u20135573.","journal-title":"J Biol Chem"},{"key":"BFonc2008502_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/oxfordjournals.annonc.a059155","volume":"6","author":"E Zucca","year":"1995","unstructured":"Zucca E, Roggero E, Pinotti G, Pedrinis E, Cappella C, Venco A et al. (1995). Patterns of survival in mantle cell lymphoma. Ann Oncol 6: 257\u2013262.","journal-title":"Ann Oncol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2008502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2008502","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2008502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T16:16:46Z","timestamp":1647879406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2008502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,9]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,3,26]]}},"alternative-id":["BFonc2008502"],"URL":"https:\/\/doi.org\/10.1038\/onc.2008.502","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,9]]},"assertion":[{"value":"14 November 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}